Correlation Between Duopharma Biotech and Insas Bhd

Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Insas Bhd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Insas Bhd into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Duopharma Biotech Bhd and Insas Bhd, you can compare the effects of market volatilities on Duopharma Biotech and Insas Bhd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Insas Bhd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Insas Bhd.

Diversification Opportunities for Duopharma Biotech and Insas Bhd

0.58

Correlation Coefficient

Duopharma Biotech  Insas Bhd

Very weak diversification

The 3 months correlation between Duopharma and Insas is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Insas Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insas Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Insas Bhd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insas Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Insas Bhd go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Insas Bhd

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the Insas Bhd. In addition to that, Duopharma Biotech is 1.32 times more volatile than Insas Bhd. It trades about -0.02 of its total potential returns per unit of risk. Insas Bhd is currently generating about 0.01 per unit of volatility. If you would invest  92.00  in Insas Bhd on December 30, 2024 and sell it today you would earn a total of  0.00  from holding Insas Bhd or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Duopharma Biotech Bhd  vs.  Insas Bhd

Duopharma Biotech Bhd

Risk-Adjusted Performance

Very Weak

Over the last 90 days Duopharma Biotech Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Insas Bhd

Risk-Adjusted Performance

Very Weak

Over the last 90 days Insas Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Insas Bhd is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Duopharma Biotech and Insas Bhd

The main advantage of trading using opposite Duopharma Biotech and Insas Bhd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Insas Bhd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insas Bhd will offset losses from the drop in Insas Bhd's long position.

The idea behind Duopharma Biotech Bhd and Insas Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.